Be The Match BioTherapies® partners with cell and gene therapy companies to save lives through autologous and allogeneic cellular therapy. We are the only cell and gene therapy solutions provider with customizable services to support the entire end-to-end cell therapy supply chain. As part of the National Marrow Donor Program®(NMDP)/Be The Match®, Be The Match BioTherapies has sourced, collected and delivered cells from more than 100,000 volunteer allogeneic donors around the world for time-critical cellular therapies. We have extensive experience providing cellular source material consented for research, clinical and commercial use. Throughout the past 35+ years, Be The Match BioTherapies has developed and continually enhanced their cell collection network and proven cell therapy supply chain infrastructure. The teams are responsible for more than 6,500 time-sensitive cell therapy shipments per year. Through the CIBMTR® (Center for International Blood and Marrow Transplant Research®), Be The Match BioTherapies provides long-term follow-up tracking for the first two FDA-approved CAR-T therapies.
We ask that you please review and follow our Community Guidelines to ensure responsible and respectful conversations: http://bit.ly/2Apu7Ja
-
Industry
-
Biotechnology Research
-
Company size
-
1,001-5,000 employees
-
Headquarters
-
Minneapolis, MN
-
Type
-
Nonprofit
-
Founded
-
2016
-
Specialties
-
cell sourcing, MatchSource software, cell therapy clinical trial network, collection network development, cell therapy logistics, supply chain case management, cell therapy supply chain, quality system audit, collection site qualification, cell therapy patient outcomes, cell therapy starting material, bioinformatics, cell therapy transport, cell therapy delivery, consented cell donors, cryopreserved cells, be the match registry, FDA requirements for cell therapy, cell therapy logistics documentation, apheresis starting material, clinical trial design, clinical trial recruitment, cell therapy customs requirements, HapLogic, cell therapy source material, custom search algorithm, cell therapy clinical research, and cord blood for cell therapy
